Shawn Barney

790 total citations
8 papers, 686 citations indexed

About

Shawn Barney is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Shawn Barney has authored 8 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Shawn Barney's work include HIV/AIDS drug development and treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and HIV Research and Treatment (2 papers). Shawn Barney is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and HIV Research and Treatment (2 papers). Shawn Barney collaborates with scholars based in United States. Shawn Barney's co-authors include Stephen R. Petteway, Kelly Guthrie, Gene Merutka, D.M. Lambert, Anick Lambert, Joel B. Erickson, Robert J. Wittrock, Israil Pendrak, Dennis M. Lambert and Mary K. Lawless and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and The Journal of Organic Chemistry.

In The Last Decade

Shawn Barney

8 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn Barney United States 5 274 253 198 176 127 8 686
Eckart Matthes Germany 16 196 0.7× 356 1.4× 224 1.1× 297 1.7× 69 0.5× 43 701
Takahide Kouno Japan 12 181 0.7× 394 1.6× 199 1.0× 108 0.6× 60 0.5× 21 659
Anne Bonhoure France 11 130 0.5× 407 1.6× 241 1.2× 80 0.5× 88 0.7× 16 759
Andrew Prussia United States 15 420 1.5× 264 1.0× 84 0.4× 150 0.9× 81 0.6× 25 779
Janet Lineberger United States 13 109 0.4× 280 1.1× 454 2.3× 237 1.3× 89 0.7× 15 824
François M. Pujol Finland 12 123 0.4× 335 1.3× 149 0.8× 59 0.3× 73 0.6× 13 657
J S Culp United States 11 136 0.5× 443 1.8× 510 2.6× 420 2.4× 55 0.4× 11 918
Holly L. MacArthur United States 9 100 0.4× 299 1.2× 170 0.9× 225 1.3× 28 0.2× 10 606
Chhaya Dharia United States 7 57 0.2× 389 1.5× 114 0.6× 181 1.0× 108 0.9× 9 599
Mireille Cartier Canada 13 229 0.8× 485 1.9× 46 0.2× 114 0.6× 40 0.3× 17 826

Countries citing papers authored by Shawn Barney

Since Specialization
Citations

This map shows the geographic impact of Shawn Barney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn Barney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn Barney more than expected).

Fields of papers citing papers by Shawn Barney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn Barney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn Barney. The network helps show where Shawn Barney may publish in the future.

Co-authorship network of co-authors of Shawn Barney

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn Barney. A scholar is included among the top collaborators of Shawn Barney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn Barney. Shawn Barney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, James K. T., Stuart Portbury, Mary Beth Thomas, et al.. (2006). Cardiac glycosides provide neuroprotection against ischemic stroke: Discovery by a brain slice-based compound screening platform. Proceedings of the National Academy of Sciences. 103(27). 10461–10466. 84 indexed citations
2.
Barney, Shawn, et al.. (1998). Pentafuside , a novel inhibitor of HIV-1 fusion and infection, is synergistic when used in combination with reverse transcriptase and protease inhibitors in vitro. Antiviral Research. 37(3). 54. 2 indexed citations
3.
Black, Paul L., Michael A. Ussery, Shawn Barney, et al.. (1996). Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice. Antiviral Research. 29(2-3). 175–186. 3 indexed citations
4.
Lambert, D.M., Shawn Barney, Anick Lambert, et al.. (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.. Proceedings of the National Academy of Sciences. 93(5). 2186–2191. 288 indexed citations
5.
Lawless, Mary K., et al.. (1996). HIV-1 Membrane Fusion Mechanism:  Structural Studies of the Interactions between Biologically-Active Peptides from gp41. Biochemistry. 35(42). 13697–13708. 153 indexed citations
6.
Pendrak, Israil, Shawn Barney, Robert J. Wittrock, D.M. Lambert, & William D. Kingsbury. (1994). ChemInform Abstract: Synthesis and Anti‐HSV Activity of A‐Ring‐Deleted Mappicine Ketone Analogue.. ChemInform. 25(44). 2 indexed citations
7.
Block, Timothy M., Shawn Barney, John L. Masonis, et al.. (1994). Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells. Journal of General Virology. 75(9). 2481–2487. 25 indexed citations
8.
Pendrak, Israil, Shawn Barney, Robert J. Wittrock, Dennis M. Lambert, & William D. Kingsbury. (1994). Synthesis and Anti-HSV Activity of A-Ring-Deleted Mappicine Ketone Analog. The Journal of Organic Chemistry. 59(9). 2623–2625. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026